The present invention relates to the use of ergot derivatives or ergolines, and in particular of lisuride and terguride for the prophylaxis and treatment of constrictive capillary arteriopathy. Constrictive capillary arteriopathy refers to the diseases pulmonary arterial hypertension, endogenously induced or exogenously induced glomeruloscleroses as well as secondary Raynaud's syndrome.

 
Web www.patentalert.com

< Topical Preparations Comprising Flower Wax And Candelilla

> STIMULATION OF CARTILAGE FORMATION USING REDUCED PRESSURE TREATMENT

> Transdermal Delivery Apparatus and Method

~ 00571